Senior Associate Scientist, Analytical Development (Contract)

About allogene

allogene.com

Allogene is a clinical-stage biotechnology company developing off-the-shelf AlloCAR T cell therapies using multiplex gene engineering and gene-editing to create allogeneic (ready-made) CAR T candidates. The company pairs a proprietary lymphodepletion approach with scalable, state-of-the-art manufacturing to optimize safety, durability, and broader patient access. Lead programs include cemacabtagene ansegedleucel (cema‑cel) for large B‑cell lymphoma (including frontline DLBCL), ALLO‑316 for renal cell carcinoma, and ALLO‑329 for autoimmune disease, alongside a broader pipeline. Allogene’s platform strategy aims to accelerate delivery of cell therapies by removing patient-specific manufacturing constraints.